Currently, patients have two main options to access experimental therapies that may treat their conditions but that have not yet been approved by the Food and Drug Administration (FDA): enrolling in a clinical trial or applying to FDA’s expanded access
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/09/27/the-proposed-federal-right-to-try-law-is-not-the-answer-for-critically-ill-patients/
Posted
Sep 27 2016, 08:00 AM
by
Health Affairs BlogHealth Affairs Blog